MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,735,271 | -32.0% | 5,043,356 | 0.0% | 4.46% | -5.3% |
| Q2 2023 | $23,149,004 | -7.3% | 5,043,356 | 0.0% | 4.71% | -11.7% |
| Q1 2023 | $24,964,612 | -9.3% | 5,043,356 | 0.0% | 5.33% | -8.0% |
| Q4 2022 | $27,536,724 | -16.0% | 5,043,356 | 0.0% | 5.80% | -0.9% |
| Q3 2022 | $32,782,000 | +37.4% | 5,043,356 | 0.0% | 5.85% | +44.6% |
| Q2 2022 | $23,855,000 | -22.2% | 5,043,356 | +15.0% | 4.04% | +24.3% |
| Q1 2022 | $30,656,000 | -9.7% | 4,385,670 | +31.7% | 3.25% | +84.3% |
| Q4 2021 | $33,933,000 | -16.5% | 3,330,000 | 0.0% | 1.77% | +4.1% |
| Q3 2021 | $40,659,000 | – | 3,330,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |